Sexual Health in Breast Cancer Patients
Sexuality and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment
2 other identifiers
observational
93
1 country
1
Brief Summary
In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2025
CompletedJanuary 28, 2026
January 1, 2026
4.9 years
October 26, 2021
January 27, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Determine changes in sexual well-being for women with breast cancer
Determine changes in sexual well-being throughout the course of breast cancer treatment, pre- and post-implementation of developed educational materials using the Sexual Health Among Women Receiving Breast Cancer Treatment Survey
1 year
Determine educational resources currently used for sexual health information
Determine patients' self reported list of educational media received regarding sexual health during breast cancer treatment using the PROM survey (BREAST-Q)
1 year
Determine educational resources currently used for sexual health information
Determine patients' self reported list of educational media received regarding sexual health during breast cancer treatment using the Sexual Health Among Women Receiving Breast Cancer Treatment Survey
1 year
Determine patients preferred type of education for sexual health
Determine the patients preferred type and timing of educational interventions for sexual health using the Sexual Health Among Women Receiving Breast Cancer Treatment Survey
1 year
Study Arms (5)
Stage 0
Ductal carcinoma in situ. Timing: start of endocrine therapy
Stages I-III Surgery first
Invasive cancer. Surgery first Timing: start of endocrine therapy
Stages I-III, neoadjuvant chemotherapy first
Invasive cancer. Neoadjuvant chemotherapy first Timing: during neoadjuvant chemotherapy
Stage IV
Metastatic cancer, chemotherapy only, no invasive surgery Timing: 2 months into treatment
Survivors
Timing: any time
Interventions
Providers with extensive training and expertise in the subject will lead the virtual focus groups over Zoom using a semi-structured guide. Topics will focus on education received from the health care team, information received from outside sources, and patient recommendations on the type and timing of information preferred. We will create an analytic report based on the focus group findings, which will be used to inform the development of educational material. Sexual well-being is currently measured longitudinally on a 0-100 point scale as a component of a validated patient-reported outcome measures (PROM) survey (BREAST-Q) distributed to all breast cancer patients. These scores will be analyzed in patients with and without educational interventions for comparison.
Eligibility Criteria
All patients diagnosed with ductal carcinoma in situ or invasive breast cancer, seen in the breast center between 9/1/2019 to present, will potentially be recruited to participate. Patients less than 18 years of age and those with non-cancer diagnoses or prior history of breast cancer will be excluded.
You may qualify if:
- Patients diagnosed with ductal carcinoma in situ or invasive breast cancer, seen in the breast center between 09/01/2019 to present, will potentially be recruited to participate.
You may not qualify if:
- Patients less than 18 years of age and those with non-cancer diagnoses or prior history of breast cancer will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Hospital
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Tevis
Colorado Research Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2021
First Posted
December 1, 2021
Study Start
December 1, 2020
Primary Completion
October 23, 2025
Study Completion
October 23, 2025
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data will not be shared with other researchers. Individual Participant Data will be housed in a deidentified format in the secure, encrypted REDCap database of the University of Colorado School od Medicine.